BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10225552)

  • 1. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
    Haustermans K; Fowler JF
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
    J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
    Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer.
    Corvò R; Paoli G; Giaretti W; Sanguineti G; Geido E; Benasso M; Margarino G; Vitale V
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):57-63. PubMed ID: 10758305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
    Dobrowsky W; Dobrowsky E; Wilson GD
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):576-82. PubMed ID: 12573744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
    Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy.
    Zackrisson B; Gustafsson H; Stenling R; Flygare P; Wilson GD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):677-83. PubMed ID: 9240632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines.
    Zackrisson B; Flygare P; Gustafsson H; Sjöström B; Wilson GD
    Eur J Cancer; 2002 May; 38(8):1100-6. PubMed ID: 12008198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
    Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
    Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report.
    Begg AC; Hofland I; Moonen L; Bartelink H; Schraub S; Bontemps P; Le Fur R; Van Den Bogaert W; Caspers R; Van Glabbeke M
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1449-53. PubMed ID: 2262369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.
    Epstein AH; Lebovics RS; Goffman T; Teague D; Fuetsch ES; Glatstein E; Okunieff P; Cook JA
    J Natl Cancer Inst; 1994 Dec; 86(23):1775-80. PubMed ID: 7966416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
    Wilson GD; Dische S; Saunders MI
    Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.
    Hui EP; Poon TC; Teo PM; Mo F; Zee B; Leung SF; Ho S; Mok TS; Kwan WH; Johnson PJ; Chan AT
    Radiother Oncol; 2003 Oct; 69(1):53-62. PubMed ID: 14597357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?
    Haustermans K; Fowler J; Geboes K; Christiaens MR; Lerut A; van der Schueren E
    Radiother Oncol; 1998 Feb; 46(2):157-67. PubMed ID: 9510043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors.
    Struikmans H; Rutgers DH; Hordijk GJ; Slootweg PJ; van der Tweel I; Battermann JJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):27-34. PubMed ID: 9422554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
    Alsner J; Høyer M; Sørensen SB; Overgaard J
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.